CAM-H2

· Precirix

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CAM-H2, covering 2025-05-06 to 2025-05-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Safety, Tolerability, Dosimetry, and Preliminary Efficacy of the HER2 Directed Radioligand CAM-H2 in Patients With Advanced/Metastatic HER2-Positive Breast, Gastric, and Gastro-Esophageal Junction (GEJ) Cancer [Phase 1, Phase 2]

See pricing